dr garon on considerations for perioperative immunotherapy use in lung cancer
Published 1 month ago • 40 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:30
dr. garon on concerns for immunotherapy combinations in lung cancer
-
1:25
dr. garon on incorporating immunotherapies into lung cancer treatment
-
0:56
dr. garon on potential for immunotherapy in egfr nsclc
-
1:04
dr. garon on the expanding treatment landscape in lung cancer
-
2:44
advances in perioperative immunotherapy in lung cancer
-
0:54
dr. garon on immunotherapy for patients with nsclc
-
1:04
dr. garon on immunotherapy in stage iii unresectable nsclc
-
5:15
integrating perioperative immunotherapy strategies in nsclc
-
1:22
dr. garon on future of immunotherapy in nsclc
-
1:14
dr. garon discusses immunotherapy as salvage treatment for advanced lung cancer
-
1:07
dr. garon on immunotherapy combinations in nsclc
-
1:25
dr. garon on antiangiogenic agents in lung cancer
-
1:12
dr. cascone on remaining challenges with perioperative immunotherapy in nsclc
-
1:01
dr. garon on the keynote-001 study in nsclc
-
1:13
dr. felip on immunotherapy alone or in combination in lung cancer
-
1:07
dr. garon on differences between antiangiogenic agents in lung cancer
-
1:55
dr. gandara on the impact of immunotherapy on the tumor microenvironment in lung cancer
-
1:10
dr. garon on the role of trastuzumab deruxtecan in lung cancer
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer